Brief: Vincerx Pharma Reports Q2 Loss Per Share Of $0.12
12/08/2021 23:13
Aug 12 (Reuters) - Vincerx Pharma Inc VINC.O :
* VINCERX PHARMA REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS AND
PROVIDES A CORPORATE UPDATE
* Q2 LOSS PER SHARE $0.12
* VINCERX PHARMA - ENDED Q2 WITH $85.6 MILLION IN CASH AND
CASH
EQUIVALENTS
Source text for Eikon: ID:nGNX8WVpcp
Further company coverage: VINC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vincerx Pharma
See all newsBrief: Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC
Brief: Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities
Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Vincerx Pharma Inc expected to post a loss of $3.40 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Aditxt, Natgas companies, DocuSign